Sofosbuvir Completed Phase 4 Trials for Hepatitis C Viral Infection / Thalassaemic disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02347345Immunologic Effects of HCV Therapy With HARVONI in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs
NCT03200184Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients
NCT03032666Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial
NCT02156570DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral)
NCT02214420SMV + SOF With/Without RBV for IFN-II Patients With CHC
NCT02992457Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Hepatitis C Infection
NCT02768961Program of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria (JAILFREE-C)